1. Dumic, J., Dabelic, S., Flögel, M.: Galectin-3: an open-ended story. Biochim Biophys Acta, Gen Subj 1760, 616–635 (2006)
2. Prieto, V.G., Mourad-Zeidan, A.A., Melnikova, V., Johnson, M.M., Lopez, A., Diwan, A.H., Lazar, A.J.F., Shen, S.S., Zhang, P.S., Reed, J.A., Gershenwald, J.E., Raz, A., Bar-Eli, M.: Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Canc Res 12, 6709–6715 (2006)
3. Nangia-Makker, P., Conklin, J., Hogan, V., Raz, A.: Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med 8, 187–192 (2002)
4. Glinsky, V.V., Huflejt, M.E., Glinsky, G.V., Deutscher, S.L., Quinn, T.P.: Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β- galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60, 2584–2588 (2000)
5. Glinsky, V.V., Glinsky, G.V., Rittenhouse-Olson, K., Huflejt, M.E., Glinskii, O.V., Deutscher, S.L., Quinn, T.P.: The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61, 4851–4857 (2001)